CompaniesAttenuon

Attenuon

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

192

By Phase

PHASE2: 3PHASE1/PHASE2: 1

By Status

UNKNOWN: 2TERMINATED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00131651
Hover over trial bars to see details

Recent Trials

NCT00405574Lead Sponsor
Study of ATN-224 in Patients With Prostate Cancer
PHASE2Unknown
50 participants
Started: Nov 30, 2006 · Completed: Sep 30, 2008
NCT00383851Lead Sponsor
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
PHASE2Unknown
60 participants
Started: Sep 30, 2006 · Completed: Sep 30, 2008
NCT00352742Lead Sponsor
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
PHASE1/PHASE2Terminated
46 participants
Started: Jun 30, 2006 · Completed: Dec 31, 2008
NCT00131651Lead Sponsor
ATN-161 in Advanced Renal Cell Cancer
PHASE2Terminated
36 participants
Started: Aug 31, 2005